Alexandra Peebles
Family · Huntsville, ALNPI 1659845972
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 148 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 19.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $746 and has fallen 78.0% since, to $164 in 2025.
Across 148 payments — averaging $14.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$413
- Novo Nordisk$270
- AstraZeneca$260
- Lilly USA, LLC$252
- Takeda Pharmaceuticals U.S.A., Inc.$212
- Kowa Pharmaceuticals America, Inc.$109
- plus $572 from 17 others
What the payments were for
- Food & beverage$2,087100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 28 | $413 |
| Novo Nordisk | 41 | $270 |
| AstraZeneca | 15 | $260 |
| Lilly USA, LLC | 14 | $252 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $212 |
| Kowa Pharmaceuticals America, Inc. | 7 | $109 |
| Antares Pharma, Inc. | 4 | $92 |
| Clarus Therapeutics Inc. | 4 | $76 |
| GSK | 3 | $60 |
| Merck | 3 | $56 |
| Tolmar, Inc. | 2 | $38 |
| Astellas Pharma US Inc | 2 | $36 |
| Amgen | 2 | $33 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $28 |
| Boehringer Ingelheim | 2 | $26 |
| IBSA Pharma Inc. | 1 | $21 |
| Johnson & Johnson | 1 | $20 |
| Exact Sciences | 1 | $19 |
| Bayer | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Genentech USA, Inc. | 1 | $13 |
| Adlon Therapeutics L.p. | 1 | $12 |
| Eisai Inc. | 1 | $11 |
How this compares
$2,087 in reported general payments places this provider in the 75th percentile of 3,415 family providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 30 | $1,093 |
| Pravastatin Sodium | 30 | $1,027 |
| Levothyroxine Sodium | 39 | $675 |
| Olmesartan Medoxomil | 20 | $557 |
| Losartan Potassium | 28 | $431 |
| Escitalopram Oxalate | 34 | $403 |
| Atorvastatin Calcium | 29 | $358 |
| Simvastatin | 20 | $272 |
| Omeprazole | 18 | $250 |
| Famotidine | 26 | $217 |
| Metformin Hcl ErMetformin Hcl | 19 | $217 |
| Rosuvastatin Calcium | 17 | $199 |
| Hydralazine Hcl | 16 | $195 |
| Lisinopril | 21 | $181 |
| Amlodipine Besylate | 22 | $117 |
Paid to pharmacies, not to this prescriber.
Other family in Huntsville
- Leigh Ann ChildressHuntsville$240K
- Christina CanteyHuntsville$118K
- Julia BettsHuntsville$27K
- Joann IkardHuntsville$19K
- Hannah GarnettHuntsville$18K
- Alyssa FikesHuntsville$15K
- Brittany HansonHuntsville$12K
- Molly ReevesAuburn$158K
- Leigh LunaMontgomery$69K
- Christopher LovellMobile$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.